加拿大家庭医疗保健市场，按类型（设备、服务和软件）、疾病（心脏病、高血压、糖尿病、慢性阻塞性肺病、肥胖症、痴呆症/阿尔茨海默病、抑郁症、哮喘、传染病（艾滋病毒/艾滋病）、帕金森病、骨关节疾病、吸烟等）行业趋势和预测到 2029 年。
加拿大家庭医疗保健市场分析与洞察
家庭护理服务帮助体弱者或有急性、慢性、姑息或康复护理需求的人在社区中独立生活，并在无法在社区生活时协调和管理进入机构护理。家庭护理服务包括护理、个人支持/家庭主妇、治疗（包括物理治疗、职业治疗、言语病理学、社会工作、营养学/营养学）、医疗用品和设备以及病例管理。
由于经济增长，人们对长期健康和保健更感兴趣。糖尿病患者需要设备来监测血糖水平、检查怀孕情况、增加对妊娠试纸的需求以及监测血压，从而导致对血糖监测仪、血压计等设备的需求增加。家庭医疗保健管理服务有助于管理糖尿病、心力衰竭或慢性阻塞性肺病 (COPD)和癌症等慢性疾病。其服务包括护理服务、临终关怀服务和药物分配。缺乏熟练的家庭护理服务提供商以及服务提供商和患者之间的协调导致治疗不规律，这可能会给加拿大家庭医疗保健市场带来挑战。加拿大家庭医疗保健市场最近出现了一些发展。
家庭医疗保健市场具有支持作用，旨在减少疾病的进展。Data Bridge Market Research 分析称，在 2022 年至 2029 年的预测期内，家庭医疗保健市场将以 8.1% 的复合年增长率增长。
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制至 2019 - 2014） |
|
定量单位 |
收入（百万美元），定价（美元） |
|
涵盖的领域 |
按类型（设备、服务和软件）、疾病（心脏病、高血压、糖尿病、慢性阻塞性肺病、肥胖症、痴呆症/阿尔茨海默病、抑郁症、哮喘、传染病（艾滋病毒/艾滋病）、帕金森病、骨关节疾病、吸烟等） |
|
覆盖国家 |
加拿大 |
|
涵盖的市场参与者 |
Medtronic、荷兰皇家飞利浦公司、ResMed、雅培、F. Hoffmann-La Roche Ltd、EXTENDICARE、Bayshore HealthCare、Fresenius Medical Care AG & Co. KGaA、3M、通用电气公司、Saint Elizabeth Healthcare、Omron Healthcare, Inc.（欧姆龙公司的子公司）、AlayaCare、Siemens Healthcare GmbH、波士顿科学公司、Cardinal Health、Fisher & Paykel Healthcare Limited、Coloplast Canada（Coloplast Group 的子公司）、Invacare Corporation、液化空气医疗系统公司（液化空气公司的子公司） |
加拿大家庭医疗保健市场动态
驱动程序
- 慢性病病例增加导致家庭医疗保健设备的使用率上升
随着经济增长，人们对长期健康和保健越来越感兴趣。糖尿病患者需要设备来监测血糖水平、检查怀孕情况，增加妊娠试纸的需求，并监测血压，对血糖监测仪、血压计等设备的需求不断增长。家庭医疗保健管理服务有助于管理糖尿病、心力衰竭或慢性阻塞性肺病 (COPD) 和癌症等慢性疾病。其服务包括护理服务、临终关怀服务和药物分配。
- 老年人口不断增加
由于老年人口更容易患慢性疾病和受伤，加拿大老年人口疾病和受伤的患病率导致对家庭医疗保健服务的需求，以监测和护理他们的健康。因此，老年人口及其不断上升的疾病率在推动家庭医疗保健市场方面发挥着重要作用。血糖仪用于监测血糖水平以便注射胰岛素；胰岛素注射剂和/或胰岛素笔可用。此外，这些国家的优惠报销政策预计将推动市场增长。
此外，主要参与者的战略举措增加、医疗技术的进步、家庭医疗保健设备的最新进展、公共和私人组织为传播意识而采取的举措增多以及政府资金的增加都是扩大家庭医疗保健市场的因素。
机会
- 远程医疗需求不断增长
远程医疗使用电子设备来监测日常健康活动。远程监测通过识别意外血压等早期预警信号，帮助避免去医院。其中包括监测血压、心率、血糖水平、氧气水平以及体重和健康状况。
此外，在预测期内（2022-2029 年），药品审批的增加将为家庭医疗保健市场提供有利的机会。此外，主要参与者的合作和协议将在未来提高家庭医疗保健市场的增长率。
限制/挑战
然而，在不同环境中工作的家庭医护人员面临着多种安全和健康危害。这些危害包括血源性病原体和生物危害、乳胶敏感性、患者抬起带来的人体工程学危害、暴力、敌对动物以及不卫生和危险的条件。不同的危害威胁着患者的安全，包括暴力或不稳定的患者、不安全的社区、潜在危险的宠物和家庭成员。患者还担心与环境相关的问题，包括室温过高、室内空气质量差以及啮齿动物和昆虫造成的不卫生条件。通过与动物、生食和受污染的无生命物体直接和间接接触而发生的病原体交叉污染传播可能会使体弱的老年人和其他人处于危险之中。
本家庭医疗保健市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关家庭医疗保健市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。
新冠肺炎疫情对家庭医疗保健市场的影响
COVID-19 给市场带来了负面影响。疫情期间的封锁和隔离使疾病管理和服药依从性变得复杂。医疗服务提供者和患者的隔离和不接触将进一步影响市场。社会隔离会增加压力、绝望和社会支持，所有这些都可能导致疫情期间服务依从性的降低。
近期发展
- 2021 年 11 月，AlayaCare 收购了专门的家庭健康解决方案提供商 Delta Health Technologies。收购 Delta Health Technologies 扩大了 AlayaCare 作为家庭健康市场软件即服务 (SaaS) 技术领先提供商的地位。这是 AlayaCare 致力于使家庭护理成为医疗保健过程中更加互联和一体化的一部分的重大进展。
加拿大家庭医疗保健市场范围
加拿大家庭医疗保健市场根据类型、疾病和分销渠道分为三个显著的细分市场。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，以便做出战略决策，确定核心市场应用。
类型
- 设备
- 服务
- 软件
根据类型，市场细分为设备、软件和服务。根据设备，市场细分为测试、筛查和监测产品、治疗、行动护理、节制护理和伤口护理。根据测试、筛查和监测产品，市场细分为血压监测仪、血糖监测仪、胆固醇监测设备、脉搏血氧仪、峰值流量计、心率监测仪、胎儿监测设备、艾滋病毒检测试剂盒、睡眠呼吸暂停监测仪、凝血监测仪、排卵和妊娠检测试剂盒、动态心电图和事件监测仪、结肠癌检测试剂盒、家庭糖化血红蛋白检测试剂盒、药物和酒精检测试剂盒、心电图/心电图设备、体温监测仪、助听器和计步器。根据治疗，市场细分为氧气输送系统、雾化器、呼吸机、透析设备、胰岛素输送设备、吸入器和其他治疗产品。根据行动护理，市场细分为手杖、拐杖、电动代步车、助行器和助行车以及轮椅。根据节制护理，市场细分为内裤和尿布、导尿管、护垫和衬垫等。根据伤口护理，市场细分为传统伤口敷料、高级伤口敷料、负压伤口治疗等。根据服务，市场细分为康复、输液治疗服务、非专业护理、孕期护理、专业护理、临终关怀和姑息治疗、技术（虚拟/远程/远程医疗）、陪护、输液治疗服务、医疗社会工作服务、耐用医疗设备服务、急性后护理服务、初级护理服务、紧急护理服务等。根据康复，市场细分为职业治疗、物理治疗和言语及语言病理学家。根据非专业护理，市场细分为家庭护理、个人护理和其他护理。根据专业护理，市场分为伤口护理、糖尿病护理、心脏和呼吸评估、疼痛管理、静脉注射治疗、癌症护理等。根据其他护理，市场分为营养护理、视力障碍护理。根据软件，市场分为代理软件、临床管理系统和临终关怀解决方案。
疾病
- 心脏病
- 高血压
- 骨关节疾病
- 糖尿病
- 慢性阻塞性肺病
- 肥胖
- 痴呆症/阿尔茨海默氏病
- 传染病（艾滋病毒/艾滋病）
- 帕金森病
- 吸烟
- 哮喘
- 沮丧
- 其他的
根据疾病，市场分为心脏病、高血压、糖尿病、慢性阻塞性肺病、肥胖症、痴呆症/阿尔茨海默病、抑郁症、哮喘、传染病（艾滋病毒/艾滋病）、帕金森病、骨关节疾病、吸烟和其他。
分销渠道
- 直接招标
- 零售销售
根据分销渠道，加拿大家庭医疗保健市场分为零售和直接招标
加拿大家庭医疗保健 市场 区域分析/见解
对介入心脏病学和外周血管设备市场进行了分析，并按上述省份、类型、疾病和分销渠道提供了市场规模见解和趋势。
市场报告涵盖的省份包括安大略省、魁北克省、不列颠哥伦比亚省、阿尔伯塔省和加拿大其他地区。
安大略省在市场份额和市场收入方面占据加拿大家庭医疗保健市场的主导地位，并将在预测期内继续保持主导地位。这是因为该地区拥有主要的关键参与者和发达的医疗保健基础设施。
竞争格局和家庭医疗保健份额分析
加拿大家庭医疗保健市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对遗传性视网膜疾病市场的关注有关。
加拿大家庭医疗保健市场的一些主要参与者包括美敦力 (Medtronic)、荷兰皇家飞利浦公司 (Koninklijke Philips NV)、瑞思迈 (ResMed)、雅培 (Abbott)、罗氏公司 (F. Hoffmann-La Roche Ltd)、EXTENDICARE、Bayshore HealthCare、Fresenius Medical Care AG & Co. KGaA、3M、通用电气公司 (General Electric Company)、圣伊丽莎白医疗保健 (Saint Elizabeth Healthcare)、欧姆龙医疗保健公司 (Omron Healthcare, Inc.，欧姆龙公司的子公司)、AlayaCare、西门子医疗保健有限公司 (Siemens Healthcare GmbH)、波士顿科学公司 (Boston Scientific Corporation)、卡德纳健康公司 (Cardinal Health)、费雪派克医疗保健有限公司 (Fisher & Paykel Healthcare Limited)、康乐保加拿大公司 (Coloplast Canada，康乐保集团的子公司)、Invacare Corporation、液化空气医疗系统 (液化空气公司的子公司) 等。
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域和供应商份额分析。如有进一步询问，请要求分析师致电。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF CANADA HOME HEALTHCARE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 CANADA HOME HEALTHCARE MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 COUNTRY SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 TYPE SEGMENT LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 SECONDARY SOURCES
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL'S MODEL
4.2 PORTER'S FIVE FORCES MODEL
4.3 CANADA UNSKILLED CARE
4.3.1 OVERVIEW
4.3.2 DOMESTIC
4.3.3 PERSONAL
5 EPIDEMIOLOGY
6 CANADA HOME HEALTHCARE MARKET: REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING CASES OF CHRONIC DISEASES LEADING TO RISING USAGE OF HOME HEALTHCARE DEVICES
7.1.2 TECHNOLOGICAL ADVANCEMENT
7.1.3 INCREASING GERIATRIC POPULATION
7.1.4 INSURANCE COVERAGE
7.2 RESTRAINTS
7.2.1 SAFETY CONCERNS
7.2.2 UNMET HOMECARE NEEDS
7.3 OPPORTUNITIES
7.3.1 EMERGING MARKETS
7.3.2 INCREASING DEMAND FOR TELEHEALTH
7.4 CHALLENGES
7.4.1 LACK OF SKILLED HOME CARE SERVICE PROVIDERS
7.4.2 LACK OF COORDINATION BETWEEN SERVICE PROVIDERS AND PATIENTS LEADS TO IRREGULARITY IN TREATMENT
8 CANADA HOME HEALTHCARE MARKET, BY TYPE
8.1 OVERVIEW
8.2 DEVICES
8.2.1 TESTING, SCREENING, & MONITORING PRODUCTS
8.2.1.1 BLOOD PRESSURE MONITORS
8.2.1.2 BLOOD GLUCOSE MONITORS
8.2.1.3 SLEEP APNEA MONITORS
8.2.1.4 PULSE OXIMETERS
8.2.1.5 HEART RATE MONITORS
8.2.1.6 HEARING AIDS
8.2.1.7 HOLTER AND EVENT MONITORS
8.2.1.8 TEMPERATURE MONITORS
8.2.1.9 ECG/EKG DEVICES
8.2.1.10 OVULATION AND PREGNANCY TEST KITS
8.2.1.11 COAGULATION MONITORS
8.2.1.12 CHOLESTEROL MONITORING DEVICES
8.2.1.13 PEAK FLOW METERS
8.2.1.14 PEDOMETERS
8.2.1.15 HIV TEST KITS
8.2.1.16 COLON CANCER TEST KITS
8.2.1.17 HOME HEMOGLOBIN A1C TEST KITS
8.2.1.18 DRUG AND ALCOHOL TEST KITS
8.2.1.19 FETAL MONITORING DEVICES
8.2.2 THERAPEUTIC PRODUCTS
8.2.2.1 INSULIN DELIVERY DEVICES
8.2.2.2 DIALYSIS EQUIPMENT
8.2.2.3 INHALERS
8.2.2.4 NEBULIZERS
8.2.2.5 OXYGEN DELIVERY SYSTEMS
8.2.2.6 VENTILATORS
8.2.2.7 IV EQUIPMENT
8.2.2.8 OTHERS
8.2.3 WOUND CARE
8.2.3.1 ADVANCED WOUND DRESSING
8.2.3.2 TRADITIONAL WOUND DRESSING
8.2.3.3 NEGATIVE PRESSURE WOUND THERAPY
8.2.3.4 OTHERS
8.2.4 MOBILITY CARE
8.2.4.1 CANES
8.2.4.2 CRUTCHES
8.2.4.3 WALKERS & ROLLATORS
8.2.4.4 WHEELCHAIRS
8.2.4.5 MOBILITY SCOOTERS
8.2.5 CONTINENCE CARE
8.2.5.1 BRIEFS & DIAPERS
8.2.5.2 UNDERPADS AND LINERS
8.2.5.3 URINARY CATHETERS
8.2.5.4 OTHERS
8.3 SERVICES
8.3.1 SKILLED NURSING CARE
8.3.1.1 CANCER CARE
8.3.1.2 CARDIAC AND RESPIRATORY ASSESSMENT
8.3.1.3 WOUND CARE
8.3.1.4 DIABETIC CARE
8.3.1.5 PAIN MANAGEMENT
8.3.1.6 IV THERAPY
8.3.1.7 OTHERS
8.3.2 REHABILITATION
8.3.2.1 OCCUPATIONAL THERAPY
8.3.2.2 PHYSICAL THERAPY
8.3.2.3 SPEECH AND LANGUAGE PATHOLOGISTS
8.3.3 UNSKILLED CARE
8.3.3.1 DOMESTIC
8.3.3.2 PERSONAL
8.3.4 HOSPICE & PALLIATIVE CARE
8.3.5 TECHNOLOGICAL (VIRTUAL/REMOTE/TELEHEALTH)
8.3.6 INFUSION THERAPY SERVICES
8.3.7 POST-ACUTE CARE SERVICES
8.3.8 PRIMARY CARE SERVICES
8.3.9 RESPIRATORY THERAPY
8.3.10 PREGNANCY CARE
8.3.11 COMPANION CARE
8.3.12 URGENT CARE SERVICES
8.3.13 MEDICAL SOCIAL WORKING SERVICES
8.3.14 DURABLE MEDICAL EQUIPMENT SERVICES
8.3.15 OTHERS
8.3.15.1 NUTRITIONAL
8.3.15.2 VISUAL IMPAIRED
8.4 SOFTWARE
8.4.1 CLINICAL MANAGEMENT SYSTEMS
8.4.2 AGENCY SOFTWARE
8.4.3 HOSPICE SOLUTIONS
9 CANADA HOME HEALTHCARE MARKET, BY DISEASE
9.1 OVERVIEW
9.2 HEART DISEASES
9.2.1 CONGESTIVE HEART FAILURE (CHF)
9.2.2 CHRONIC ISCHEMIC HEART DISEASE (CHD)
9.2.3 CORONARY ARTERY DISEASE
9.2.4 OTHER DISEASES
9.3 HYPERTENSION
9.4 DEMENTIA/ALZHEIMER'S DISEASES
9.5 DIABETES
9.6 PARKINSON'S DISEASES
9.7 DEPRESSION
9.8 OBESITY
9.9 CHRONIC OBSTRUCTIVE PULMONARY DISEASES
9.1 ASTHMA
9.11 INFECTIVE DISEASES (HIV/AIDS)
9.12 BONE AND JOINT DISEASES
9.13 SMOKING
9.14 OTHERS
10 CANADA HOME HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT TENDERS
10.3 RETAIL SALES
11 CANADA HOME HEALTHCARE MARKET, BY PROVINCE
11.1 OVERVIEW
11.2 ONTARIO
11.3 QUEBEC
11.4 BRITISH COLOMBIA
11.5 ALBERTA
11.6 REST OF CANADA
12 CANADA HOME HEALTHCARE MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: CANADA
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 MEDTRONIC
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENTS
14.1.4.1 APPROVALS
14.1.4.2 COLLABORATION
14.2 KONINKLIJKE PHILIPS N.V.
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENTS
14.2.4.1 ACQUISITION
14.2.4.2 PRODUCT LAUNCH
14.3 RESMED
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 PRODUCT PORTFOLIO
14.3.4 RECENT DEVELOPMENT
14.3.4.1 ACQUSITION
14.3.4.2 PRODUCT LAUNCHES
14.4 ABBOTT
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.4.4.1 PRODUCT LAUNCHES
14.4.4.2 AGREEMENTS
14.5 F. HOFFMANN-LA ROCHE LTD.
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 PRODUCT PORTFOLIO
14.5.4 RECENT DEVELOPMENT
14.5.4.1 PRODUCT LAUNCHES
14.6 EXTENDICARE
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 SERVICE PORTFOLIO
14.6.4 RECENT DEVELOPMENT
14.6.4.1 AGREEMENT
14.7 BAYSHORE HEALTHCARE
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENT
14.7.3.1 LAUNCH
14.7.3.2 CONTRACT
14.7.3.3 ACQUISITION
14.8 FRESENIUS MEDICAL CARE AG & CO. KGAA
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENT
14.9 3M
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT DEVELOPMENT
14.1 AIR LIQUIDE MEDICAL SYSTEMS (A SUBSIDIARY OF AIR LIQUIDE)
14.10.1 COMPANY SNAPSHOT
14.10.2 REVENUE ANALYSIS
14.10.3 PRODUCT PORTFOLIO
14.10.4 RECENT DEVELOPMENT
14.11 GENERAL ELECTRIC COMPANY
14.11.1 COMPANY SNAPSHOT
14.11.2 REVENUE ANALYSIS
14.11.3 PRODUCT PORTFOLIO
14.11.4 RECENT DEVELOPMENTS
14.11.4.1 ACQUISITION
14.12 INVACARE CORPORATION
14.12.1 COMPANY SNAPSHOT
14.12.2 REVENUE ANALYSIS
14.12.3 PRODUCT PORTFOLIO
14.12.4 RECENT DEVELOPMENTS
14.12.4.1 LAUNCH
14.13 SAINT ELIZABETH HEALTH CARE
14.13.1 COMPANY SNAPSHOT
14.13.2 SERVICE PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.13.3.1 AWARD
14.13.3.2 ACQUISITION
14.14 SIEMENS HEALTHCARE GMBH
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT DEVELOPMENT
14.15 ALAYACARE
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENTS
14.15.3.1 AGREEMENTS
14.16 OMRON HEALTHCARE, INC. (A SUBSIDIARY OF OMRON CORPORATION)
14.16.1 COMPANY SNAPSHOT
14.16.2 REVENUE ANALYSIS
14.16.3 PRODUCT PORTFOLIO
14.16.4 RECENT DEVELOPMENTS
14.16.4.1 AGREEMENTS
14.17 BOSTON SCIENTIFIC CORPORATION
14.17.1 COMPANY SNAPSHOT
14.17.2 REVENUE ANALYSIS
14.17.3 PRODUCT PORTFOLIO
14.17.4 RECENT DEVELOPMENT
14.18 CARDINAL HEALTH
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENT
14.18.4.1 PARTNERSHIP
14.19 COLOPLAST CANADA (A SUBSIDIARY OF COLOPLAST GROUP)
14.19.1 COMPANY SNAPSHOT
14.19.2 REVENUE ANALYSIS
14.19.3 PRODUCT PORTFOLIO
14.19.4 RECENT DEVELOPMENT
14.2 FISHER & PAYKEL HEALTHCARE LIMITED
14.20.1 COMPANY SNAPSHOT
14.20.2 REVENUE ANALYSIS
14.20.3 PRODUCT PORTFOLIO
14.20.4 RECENT DEVELOPMENT
14.20.4.1 PRODUCT LAUNCH
15 QUESTIONNAIRE
16 RELATED REPORTS
表格列表
TABLE 1 CANADA HEALTHACARE (2018-2009)
TABLE 2 CANADA HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 3 CANADA DEVICES IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 4 CANADA TESTING, SCREENING, & MONITORING PRODUCTS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 5 CANADA THERAPEUTIC PRODUCTS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 6 CANADA WOUND CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 7 CANADA MOBILITY CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 8 CANADA CONTINENCE CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 9 CANADA SERVICES IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 10 CANADA SKILLED NURSING CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 11 CANADA REHABILIATION IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 12 CANADA UNSKILLED CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 13 CANADA OTHERS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 14 CANADA SOFTWARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 15 CANADA HOME HEALTHCARE MARKET, BY DISEASE, 2020-2029 (USD MILLION)
TABLE 16 CANADA HEART DISEASES IN HOME HEALTHCARE MARKET, BY DISEASE, 2020-2029 (USD MILLION)
TABLE 17 CANADA HOME HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 18 CANADA HOME HEALTHCARE MARKET, BY PROVINCE, 2020-2029 (USD MILLION)
TABLE 19 ONTARIO HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 20 ONTARIO DEVICES IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 21 ONTARIO TESTING, SCREENING, & MONITORING PRODUCTS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 22 ONTARIO THERAPEUTIC PRODUCTS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 23 ONTARIO WOUND CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 24 ONTARIO MOBILITY CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 25 ONTARIO CONTINENCE CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 26 ONTARIO SERVICES IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 27 ONTARIO SKILLED NURSING CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 28 ONTARIO REHABILITATION IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 29 ONTARIO UNSKILLED CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 30 ONTARIO OTHERS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 31 ONTARIO SOFTWARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 32 ONTARIO HOME HEALTHCARE MARKET, BY DISEASE, 2020-2029 (USD MILLION)
TABLE 33 ONTARIO HEART DISEASES IN HOME HEALTHCARE MARKET, BY DISEASE, 2020-2029 (USD MILLION)
TABLE 34 ONTARIO HOME HEALTHCARE MARKET, DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 35 QUEBEC HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 36 QUEBEC DEVICES IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 37 QUEBEC TESTING, SCREENING, & MONITORING PRODUCTS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 38 QUEBEC THERAPEUTIC PRODUCTS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 39 QUEBEC WOUND CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 40 QUEBEC MOBILITY CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 41 QUEBEC CONTINENCE CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 42 QUEBEC SERVICES IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 43 QUEBEC SKILLED NURSING CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 44 QUEBEC REHABILITATION IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 45 QUEBEC UNSKILLED CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 46 QUEBEC OTHERS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 47 QUEBEC SOFTWARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 48 QUEBEC HOME HEALTHCARE MARKET, BY DISEASE, 2020-2029 (USD MILLION)
TABLE 49 QUEBEC HEART DISEASES IN HOME HEALTHCARE MARKET, BY DISEASE, 2020-2029 (USD MILLION)
TABLE 50 QUEBEC HOME HEALTHCARE MARKET, DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 51 BRITISH COLOMBIA HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 52 BRITISH COLOMBIA DEVICES IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 53 BRITISH COLOMBIA TESTING, SCREENING, & MONITORING PRODUCTS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 54 BRITISH COLOMBIA THERAPEUTIC PRODUCTS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 55 BRITISH COLOMBIA WOUND CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 56 BRITISH COLOMBIA MOBILITY CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 57 BRITISH COLOMBIA CONTINENCE CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 58 BRITISH COLOMBIA SERVICES IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 59 BRITISH COLOMBIA SKILLED NURSING CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 60 BRITISH COLOMBIA REHABILITATION IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 61 BRITISH COLOMBIA UNSKILLED CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 62 BRITISH COLOMBIA OTHERS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 63 BRITISH COLOMBIA SOFTWARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 64 BRITISH COLOMBIA HOME HEALTHCARE MARKET, BY DISEASE, 2020-2029 (USD MILLION)
TABLE 65 BRITISH COLOMBIA HEART DISEASES IN HOME HEALTHCARE MARKET, BY DISEASE, 2020-2029 (USD MILLION)
TABLE 66 BRITISH COLOMBIA HOME HEALTHCARE MARKET, DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 67 ALBERTA HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 68 ALBERTA DEVICES IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 69 ALBERTA TESTING, SCREENING, & MONITORING PRODUCTS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 70 ALBERTA THERAPEUTIC PRODUCTS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 71 ALBERTA WOUND CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 72 ALBERTA MOBILITY CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 73 ALBERTA CONTINENCE CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 74 ALBERTA SERVICES IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 75 ALBERTA SKILLED NURSING CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 76 ALBERTA REHABILITATION IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 77 ALBERTA UNSKILLED CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 78 ALBERTA OTHERS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 79 ALBERTA SOFTWARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 80 ALBERTA HOME HEALTHCARE MARKET, BY DISEASE, 2020-2029 (USD MILLION)
TABLE 81 ALBERTA HEART DISEASES IN HOME HEALTHCARE MARKET, BY DISEASE, 2020-2029 (USD MILLION)
TABLE 82 ALBERTA HOME HEALTHCARE MARKET, DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 83 REST OF CANADA HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)
图片列表
FIGURE 1 CANADA HOME HEALTHCARE MARKET: SEGMENTATION
FIGURE 2 CANADA HOME HEALTHCARE MARKET: DATA TRIANGULATION
FIGURE 3 CANADA HOME HEALTHCARE MARKET: DROC ANALYSIS
FIGURE 4 CANADA HOME HEALTHCARE MARKET: REGIONAL VS COUNTRY ANALYSIS
FIGURE 5 CANADA HOME HEALTHCARE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 CANADA HOME HEALTHCARE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 CANADA HOME HEALTHCARE MARKET: DBMR POSITION GRID
FIGURE 8 CANADA HOME HEALTHCARE MARKET: SEGMENTATION
FIGURE 9 TECHNOLOGICAL ADVANCEMENT AND INCREASING GERIATRIC POPULATION IS EXPECTED TO DRIVE THE CANADA HOME HEALTHCARE MARKET FROM 2022 TO 2029
FIGURE 10 DEVICES SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE CANADA HOME HEALTHCARE MARKET FROM 2022 & 2029
FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL HOME HEALTHCARE MARKET
FIGURE 12 CANADA HOME HEALTHCARE MARKET: BY TYPE, 2021
FIGURE 13 CANADA HOME HEALTHCARE MARKET: BY TYPE, 2022-2029 (USD MILLION)
FIGURE 14 CANADA HOME HEALTHCARE MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 15 CANADA HOME HEALTHCARE MARKET: BY TYPE, LIFELINE CURVE
FIGURE 16 CANADA HOME HEALTHCARE MARKET: BY DISEASE, 2021
FIGURE 17 CANADA HOME HEALTHCARE MARKET: BY DISEASE, 2022-2029 (USD MILLION)
FIGURE 18 CANADA HOME HEALTHCARE MARKET: BY DISEASE, CAGR (2022-2029)
FIGURE 19 CANADA HOME HEALTHCARE MARKET: BY DISEASE, LIFELINE CURVE
FIGURE 20 CANADA HOME HEALTHCARE MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 21 CANADA HOME HEALTHCARE MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 22 CANADA HOME HEALTHCARE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 23 CANADA HOME HEALTHCARE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 24 CANADA HOME HEALTHCARE MARKET: COMPANY SHARE 2021 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
